Skip to main content

Pavaki Capital Management LLC

Position in ESPR — Esperion Therapeutics, Inc.

CIK 2143027

Position in ESPR

as of Mar 31, 2026 · filed Aug 7, 2026
Position Value
$0
New position
Shares Held
410,000
first reported quarter
Ownership
0.159%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority Sole 100% Shared 0% None 0%

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Pavaki Capital Management LLC holds $1,307,674 across 2 Drug Manufacturers - Specialty & Generic names.

# Ticker Company Shares Value (USD) Open

All Filings in ESPR

Export CSV
1 filing row on record
Report Date Value (USD) Shares
2026-03-31 410,000